University of Western Brittany
Also known as: Brest (FR), University College Hospital | Brest Hospital | Brest Teaching Hospital | Cavale Blanche - University Hospital of Brest | Centre Hospitalier Régional et Universitaire de Brest | CH Morlaix | CHRU Brest | CHRU de Brest | CHU Brest | CHU Brest - Hopital De La Cavale Blanche | CHU de Brest | CHU of Brest | Department of Hematology, Brest Teaching Hospital | EA3878 (GETBO), Brest University Hospital in France | EA3878 - University Hospital of Brest | Hématologie Clinique-Institut de Cancéro-Hématologie | HOPITAL MORVAN - BREST | Internal Medecine and pneumology department of university hospital of Brest (FRANCE) | University Hospital, Brest | university hospital of Brest | University hospital of Brest | University of Brest
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2006Last known activity
Dec 12, 2025
Timeline
1970s
- Jun 1, 1971
University of Western Brittany— Founded
Drugs by trial phase (83 distinct, 70 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (53 own, 0 via acquisition)
Phase 2 (17 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (9 own, 0 via acquisition)
Indications
Studied for
- Abortion, Habitual
- Abortion, Spontaneous
- Acute Lung Injury
- Atrial Fibrillation
- Autistic Disorder
- Brain Injuries
- Brain Injuries, Traumatic
- Brugada Syndrome
- Carcinoma, Non-Small-Cell Lung
- Cerebral Palsy
- Coronary Artery Disease
- Coronary Disease
- Cystic Fibrosis
- Delirium
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Embolism
- Fibrosis
- Fractures, Bone
- Gastroenteritis
- Gastrointestinal Hemorrhage
- Giant Cell Arteritis
- Heart Diseases
- Hemorrhage
- Hip Fractures
- Hyperhidrosis
- Kidney Failure, Chronic
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Multiple Myeloma
- Muscular Dystrophies
- Muscular Dystrophy, Oculopharyngeal
- Myeloproliferative Disorders
- Myocardial Ischemia
- Neonatal Brachial Plexus Palsy
- Neoplasm Metastasis
- Neoplasms, Plasma Cell
- Obesity
- Obesity, Morbid
- Paralysis
- Pericarditis
- Polymyalgia Rheumatica
- Prolapse
- Pruritus
- Psoriasis
- Pulmonary Disease, Chronic Obstructive
- Pulmonary Embolism
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Retinal Neoplasms
- Retinoblastoma
- Sjogren's Syndrome
- Small Cell Lung Carcinoma
- Subarachnoid Hemorrhage
- Syndrome
- Thromboembolism
- Thrombosis
- Venous Thromboembolism
- Venous Thrombosis
Recent trials (50)
- NCT07279688Lead sponsorPhase 3Dec 12, 2025
- NCT07118644Lead sponsorPhase 3Sep 1, 2025
- NCT06892951CollaboratorPhase 1/Phase 2Jun 30, 2025
- NCT06845423Lead sponsorPhase 4Apr 30, 2025
- NCT06845423OfficialPhase 4Apr 30, 2025
- NCT06819644Lead sponsorPhase 3Feb 28, 2025
- NCT06435299Lead sponsorPhase 3Jan 1, 2025
- NCT06585020CollaboratorPhase 2Oct 31, 2024
- NCT06642844CollaboratorPhase 3Oct 30, 2024
- NCT06495372Lead sponsorPhase 3Aug 31, 2024
- NCT06252870OfficialPhase 2Jul 18, 2024
- NCT06229288OfficialPhase 3Apr 25, 2024
- NCT05997979Overall official - principal investigatorPhase 2Dec 1, 2023
- NCT05997979Lead sponsorPhase 2Dec 1, 2023
- NCT05512403Overall official - principal investigatorPhase 3Jan 30, 2023
Details
- Founded
- Brest, FR Jun 1, 1971
- Last known activity
- Dec 12, 2025